VAISHALI PHARMA
Back to Cashflow Statement
|
VAISHALI PHARMA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹18 Cr | ₹-1.42 Cr | ₹-1.73 Cr | ₹0.42 Cr | ₹-1.81 Cr |
What is the latest Cash Flow from Financing Activities ratio of VAISHALI PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹-1.42 Cr |
| Mar2023 | ₹-1.73 Cr |
| Mar2022 | ₹0.42 Cr |
| Mar2021 | ₹-1.81 Cr |
How is Cash Flow from Financing Activities of VAISHALI PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | Positive | |
| Mar2024 | ₹-1.42 Cr | Negative | |
| Mar2023 | ₹-1.73 Cr | Negative | |
| Mar2022 | ₹0.42 Cr | Positive | |
| Mar2021 | ₹-1.81 Cr | - | |
Compare Cash Flow from Financing Activities of peers of VAISHALI PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VAISHALI PHARMA | ₹103.6 Cr | 2.5% | -7% | -52.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,402.0 Cr | 1.2% | -0.9% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,277.0 Cr | 2.7% | -3.8% | 5.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,140.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹107,398.0 Cr | -0.1% | -8.2% | -8.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,378.0 Cr | 2.7% | 7.1% | 2.8% | Stock Analytics | |
VAISHALI PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VAISHALI PHARMA | 2.5% |
-7% |
-52.5% |
| SENSEX | 0.4% |
-0.2% |
6.9% |
You may also like the below Video Courses